Predictors of inconclusive sophiA DDM™ HRD results in epithelial ovarian cancer
2026 · International Journal of Gynecological Cancer · 0 citations
https://doi.org/10.1016/j.ijgc.2025.103117
C
Claudia Marchetti
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
0
Papers
0
Citations
Claudia Marchetti is an academic researcher.
Papers by this author
worksStereotactic radiotherapy versus secondary cytoreduction in the management of first recurrence during and after PARP inhibitor maintenance in ovarian cancer: A propensity matched analysis
2026 · International Journal of Gynecological Cancer · 0 citations
https://doi.org/10.1016/j.ijgc.2025.102917
Comparative analysis of primary ovarian mucinous cancer versus ovarian metastasis from gastrointestinal and biliopancreatic mucinous carcinoma: towards a diagnostic algorithm.
2026 · International Journal of Gynecological Cancer · 0 citations
https://doi.org/10.1016/j.ijgc.2025.103892
Adjuvant chemotherapy after pelvic exenteration for gynecologic malignancies is associated with improved survival in patients with pelvic lymph node metastasis: a sub-analysis from the COREPEX study
2026 · International Journal of Gynecological Cancer · 0 citations
https://doi.org/10.1016/j.ijgc.2025.103065
Germline pathogenic variants identification through comprehensive cancer genome profiling in a cohort of ovarian and endometrial cancer patients
2026 · International Journal of Gynecological Cancer · 0 citations
https://doi.org/10.1016/j.ijgc.2025.103180
Association between BRCA1/2 mutation and chemotherapy response score in high grade advanced ovarian cancer: a retrospective cohort study
2026 · International Journal of Gynecological Cancer · 0 citations
https://doi.org/10.1016/j.ijgc.2025.103109
Chat about Author
Papers
Chat
Click to start Chat